invoX Belgium (formerly Softhale NV)

STAY INFORMED ABOUT THE LATEST REPORT FROM 𝐈𝐧𝐭𝐞𝐥𝐥𝐞𝐜𝐭𝐮𝐚𝐥 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 COVERS 𝐁𝐲 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬, 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧𝐬, 𝐕𝐚𝐫𝐢𝐨𝐮𝐬 𝐑𝐞𝐠𝐢𝐨𝐧𝐬 INCLUDING:  #  #Europe #AsiaPacific #LatinAmerica and #Africa.   Asthma Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (Anti-Inflammatory Drugs, Bronchodilators, Combination Therapies), By Product Type (Inhalers, Dry Powder Inhalers, Metered Dose Inhalers, Soft Mist Inhalers, Nebulizers, Pneumatic Nebulizers, Ultrasonic Nebulizers, Mesh Nebulizers), By Treatment Type (Quick-Relief Medications, Long-Term Asthma Control Medications), By Route of Administration (Inhalation, Oral, Parenteral), Global Economy Insights, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2023 - 2031 👤IMIR Market Research Pvt. Ltd. Don't miss out on this opportunity to stay informed about the latest trends in the Industry.   📚𝐆𝐞𝐭 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐀𝐭 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭𝐞𝐝 𝐏𝐫𝐢𝐜𝐞:📝👇https://lnkd.in/dj6B2RzH   📚𝐑𝐞𝐩𝐨𝐫𝐭 𝐅𝐨𝐜𝐮𝐬𝐞𝐝 𝐎𝐧 𝐓𝐨𝐩 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬: AstraZeneca Philips Teva Pharmaceuticals GSK Sanofi CareFusion Sunovion Pharmaceuticals Boehringer Ingelheim Roche Diagnostics India, Neighbouring Markets Merck Group Abbott Amgen AstraZeneca BD Biogen Boehringer Ingelheim Boston Scientific CHIESI FARMACEUTICI S.P.A. Roche Kare Medical Medtronic Merck Healthcare Merck Group MERXIN Ltd Mylan Novartis Parekhplast India Ltd Pfizer Regeneron Sanofi Shenzhen Aeon Technology Co., Ltd Softhale NV TakedaPharmaceutical Nordics AB Trudell Medical International Viatris Wellinks #AsthmaTherapeutics #Intellectualmarketinsightresearch #Marketresearchreports #Size #Share #Trends #Growth #Opportunity #Outlook #Forecast #Segments #KeyPlayers #RegionsOutlook #GrowthPotential #PriceTrends #CompetitiveMarket #Forecast #2023o2031

We are excited to announce that Softhale N.V. has changed its name to invoX Belgium N.V. We are now a part of invoX Pharma, a research-driven global biopharmaceutical company that acquired Softhale in March 2021.   The team will be known as the Respiratory Innovation Centre and we look forward to continuing our innovative work in respiratory medicine and the exciting development of the Softhaler®.   For more information about us, visit www.invoxpharma.com